Isatuximab Subcutaneous by On-Body Injector Versus Isatuximab Intravenous Plus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Phase III IRAKLIA Study — Sikander Ailawadhi (2025) | RDL Network
Isatuximab Subcutaneous by On-Body Injector Versus Isatuximab Intravenous Plus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Phase III IRAKLIA Study
Article 2025 en
Authors
SA
Sikander Ailawadhi
IŠ
Ivan Špıčka
AS
Andrew Spencer
Abstract
1 min read
IRAKLIA demonstrated efficacy and pharmacokinetic noninferiority between Isa OBI and IV. No unexpected safety signal was observed, with excellent local tolerability of Isa OBI. Efficacy and safety were comparable with Isa IV in ICARIA-MM, except the lower OBI infusion reaction rate. These results support potential use of the OBI, designed to improve practice efficiency.
Jin Lu, Albert Oriol, Alejandro Berkovits, Andrew Spencer, César Cinesi Gómez, Chunrui Li, Claudio Cerchione, Fei Li, Fredrik Schjesvold, Gurdeep Parmar, Ivan Špıčka, Marek Hus, Maria Del Rosario Custidiano, Meletios A Dimopoulos, Péter Rajnics, Sevgi Kalayoğlu Beşışık, Sikander Ailawadhi, Silvia Ling, Vânia Hungria, Xavier Leleu, Florence Suzan Teisserenc, Maya Stefanova-Urena, Rick Zhang, Victorine Koch, Dorothée Sémiond
Sikander Ailawadhi, Ivan Špıčka, Andrew Spencer, Jin Lu, Albert Oriol, Silvia Ling, Fredrik Schjesvold, Alejandro Berkovits, Marek Hus, Chunrui Li, Meletios A Dimopoulos, Péter Rajnics, Sevgi Kalayoğlu Beşışık, Vânia Hungria, Maria Del Rosario Custidiano, Gurdeep Parmar, Xavier Leleu, Fei Li, Claudio Cerchione, César Cinesi Gómez, Tadao Ishida,
Paul G. Richardson, Aurore Perrot, Jesús F. San Miguel, Meral Beksaç, Ivan Špıčka, Xavier Leleu, Fredrik Schjesvold, Philippe Moreau, Meletios A Dimopoulos, Jeffrey Huang, Jiří Minařík, Michèle Cavo, H. Miles Prince, Cheng Zheng, Franck Dubin, Helgi van de Velde, Kenneth C. Anderson
Fredrik Schjesvold, Sara Bringhen, Paul G. Richardson, Aurore Perrot, Xavier Leleu, Philippe Moreau, Meletios A Dimopoulos, Cyrille Hulin, Christina Tekle, Meredith C. Foster, Elizabeth M. Poole, Helgi van de Velde, Thierry Façon
Discussion(0)
No comments yet. Be the first to comment.